Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
The original intent had been to analyze data on 100 chemotherapy cycles in 100 subjects. Instead, in order to accelerate accrual, we analyzed data on 1 cycle in 24 subjects and 2 cycles in 40 subjects.

Reporting Groups

	Description
Patients With Colorectal Cancer Starting Chemotherapy	patients starting chemotherapy for stage 3 or 4 colorectal cancer on regimens containing oxaliplatin. The chemotherapy is not part of the study but instead is initiated as standard care.

Participant Flow:   Overall Study

	Patients With Colorectal Cancer Starting Chemotherapy
STARTED	64
COMPLETED	64
NOT COMPLETED	0

Reporting Groups

	Description
Patients With Colorectal Cancer Starting Chemotherapy	patients starting chemotherapy for stage 3 or 4 colorectal cancer on regimens containing oxaliplatin. The chemotherapy is not part of the study but instead is initiated as standard care.

Baseline Measures

	Patients With Colorectal Cancer Starting Chemotherapy
Number of Participants   [units: participants]	64
Age   [units: participants]
<=18 years	0
Between 18 and 65 years	38
>=65 years	26
Gender   [units: participants]
Female	30
Male	34
Region of Enrollment   [units: participants]
United States	64

1.  Primary:

Percentages of Participants by Gender Who Reported Nausea During the First Week of Chemotherapy   [ Time Frame: Week 1 of FOLFOX chemotherapy ]

2.  Primary:

Impact of Nausea and Vomiting on the Patient's Quality of Life as Measured by the Functional Living Index – Emesis Scale at 5-7 Days   [ Time Frame: Week 1 ]

3.  Primary:

Number of Participants by History of Nausea Who Reported Nausea During the First Week of Chemotherapy   [ Time Frame: week 1 ]

4.  Post-Hoc:

Number of Participants by Antiemetic Regimen Who Reported Nausea During First Cycle of Chemotherapy   [ Time Frame: Week 1 ]